Hospital
Chca Conroe LP
Chca Conroe LP was paid $12.79M by Medicaid between Dec 2019 and Dec 2024, across 60 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 35% of everything it billed.
33Billing provider infoCHCA CONROE LP
CONROE, TX 77304
CONROE, TX 77304
33aNPI1962455816assigned 05/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.79M
24GClaims84,394
24DCodes billed60
24AFirst – last monthDec 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Texas
Rank by total paid#13 of 109
Median peer was paid$1.15M
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 53 | $12.80 | |
| 2020 | 2,301 | $786K | |
| 2021 | 17,091 | $3.83M | |
| 2022 | 24,770 | $3.42M | |
| 2023 | 27,998 | $3.07M | |
| 2024incomplete | 12,181 | $1.69M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 35% | 1,143 | 1,069 | $4.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 8,755 | 8,221 | $4.00M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 13,074 | 12,617 | $1.77M |
| G0330 | Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room | 6.4% | 541 | 492 | $814K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 6.1% | 169 | 167 | $781K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.5% | 2,495 | 2,274 | $194K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.1% | 61 | 57 | $137K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 4,024 | 3,943 | $92K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,773 | 5,306 | $76K |
| 87400 | <1% | 3,023 | 2,954 | $58K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | <1% | 686 | 600 | $53K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 668 | 602 | $45K |
48 more codes
| 85027 | <1% | 10,404 | $44K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 273 | $39K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,074 | $35K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,665 | $24K |
| 80053 | Comprehensive metabolic panel | <1% | 1,833 | $23K |
| 81001 | <1% | 6,589 | $19K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,637 | $14K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 120 | $9K |
| 88300 | <1% | 203 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 59 | $8K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 192 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 245 | $7K |
| 80076 | <1% | 965 | $6K | |
| 84702 | <1% | 883 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 573 | $6K |
| 84484 | <1% | 1,116 | $3K | |
| 83690 | <1% | 1,085 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 29 | $2K |
| 87081 | <1% | 483 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 90 | $2K |
| 81025 | <1% | 254 | $975.52 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 31 | $739.98 |
| 86756 | <1% | 74 | $717.91 | |
| 82248 | <1% | 455 | $322.57 | |
| 86901 | <1% | 217 | $321.48 | |
| 86900 | <1% | 218 | $321.32 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 439 | $216.08 |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $108.97 |
| 85610 | <1% | 155 | $69.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 63 | $69.49 |
| 85730 | <1% | 111 | $67.68 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 57 | $60.59 |
| 94760 | <1% | 14 | $52.40 | |
| 83735 | <1% | 74 | $39.77 | |
| 85018 | <1% | 62 | $39.54 | |
| 85014 | <1% | 62 | $39.54 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 37 | $34.22 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 120 | $26.35 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 47 | $19.70 |
| J2704 | Injection, propofol, 10 mg | <1% | 85 | $3.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 14 | $3.12 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 69 | $0.00 |
| A9270 | Non-covered item or service | 0% | 645 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 47 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 12 | $0.00 |
| G1003 | Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program | 0% | 58 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 20 | $0.00 |
| C1758 | Catheter, ureteral | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRAZIER, BRANDON (CFO)